ElevateBio
Latest round
- Series D
Last raised
- May 2023
Total raised
- $1.2B
Investors
- 18
About ElevateBio
Based in Massachusetts, US, and founded in 2017, ElevateBio, LLC operates as a biotechnology company that develops novel cell and gene therapies through gene editing and induced pluripotent stem cells. The company was co-founded by David Hallal who is also the CEO and Chairman of the company. The company has also announced three spin-out companies: AlloVir, HighPassBio and Life Edit Therapeutics with each focussing on a specific therapeutic. The company also announced their joining with LifeEDIT Therapeutics in 2020. The company has also partnered with academic research institutions and biotech companies for bringing their technology to market. The company operates on a B2B business model which focusses on both developing and commercializing its own therapies. Each spin-out of the company is dedicated to the development and manufacturing of a specific type of therapeutic approach like the spin-out AlloVir is working on T cell immunotherapy for addressing COVID-19 and viruses that specifically arise stem cell transplantations and is already in the later stages of clinical trials. Another spin-out company HighPassBio is developing T-cell therapies to combat potential relapse of leukaemia following a transplant.
Who invested in ElevateBio
18 investors across 4 rounds
See all investors in ElevateBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ElevateBio
Who invested in ElevateBio?
ElevateBio has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ElevateBio raised?
ElevateBio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did ElevateBio last raise money?
ElevateBio's most recent round on record is a Series D, in May 2023.
What does ElevateBio do?
Based in Massachusetts, US, and founded in 2017, ElevateBio, LLC operates as a biotechnology company that develops novel cell and gene therapies through gene editing and induced pluripotent stem cells.
Where is ElevateBio headquartered?
ElevateBio is headquartered in Waltham, US.
Which VCs invest in companies like ElevateBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ElevateBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like ElevateBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.